Sources | Names Used |
---|---|
CCLE, FIMM | Vandetanib |
CTRPv2 | vandetanib |
PharmacoGx | Vandetanib |
Database | Identifier |
---|---|
Smiles: | CN1CCC(CC1)COC2=C(C=C3C(=C2)N=CN=C3NC4=C(C=C(C=C4)Br)F)OC |
Inchikey: | UHTHHESEBZOYNR-UHFFFAOYSA-N |
Pubchem: | 3081361 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | A2ML1 | CCLE | pan-cancer | AAC | 0.14 | 0.003 |
mRNA | ABCA12 | CCLE | pan-cancer | AAC | 0.19 | 7e-05 |
mRNA | ABHD10 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.006 |
mRNA | ABI2 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.004 |
mRNA | ABL2 | CCLE | pan-cancer | AAC | -0.13 | 0.008 |
mRNA | AC007325.2 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
mRNA | AC007325.4 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
mRNA | AC008522.1 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.01 |
mRNA | AC010184.1 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |
mRNA | AC069499.1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |